In this article, we discuss the 9 stocks Masayoshi Son is selling in 2022.
Keep Reading →
May 25 - Hedge Funds, News - Comments
In this article, we discuss the 2022 portfolio of Korean-Japanese Billionaire Masayoshi Son and the 10 stocks to watch.
Keep Reading →
May 24 - Hedge Funds, News - Comments
Below is the list of top 5 stock picks of billionaire Masayoshi Son.
Keep Reading →
March 20 - Hedge Funds, News - Comments
In this article, we discuss 10 innovative stocks in Cathie Wood’s portfolio that failed to impress.
Keep Reading →
February 28 - Hedge Funds, News - Comments
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming.
Keep Reading →
February 23 - Hedge Funds, News - Comments
In this article, we discuss the 5 latest stock picks in Harvard University’s stock portfolio.
Keep Reading →
December 17 - Hedge Funds, News - Comments
In this article, we will discuss the 10 best genomics stocks to buy now.
Keep Reading →
December 17 - Hedge Funds, News - Comments
In this article, we discuss the 5 very cheap stocks to buy right now.
Keep Reading →
December 15 - Hedge Funds, News - Comments
In this article we will take a look at whether hedge funds think Pacific Biosciences of California, Inc. (NASDAQ:PACB) is a good investment right now.
Keep Reading →
December 12 - Hedge Funds, News - Comments
In this article, we discuss the 10 Reddit stocks that flopped in 2021.
Keep Reading →
November 26 - Hedge Funds, News - Comments
In this piece, we will take a look at Japanese billionaire Masayoshi Son's investments: Top 5 stock picks. If you want to take a detailed look at Mr.
Keep Reading →
November 26 - Hedge Funds, News - Comments
In this article, we discuss Cathie Wood is Buying These 5 Stocks.
Keep Reading →
November 19 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
October 18 - Hedge Funds, News - Comments
DEVON Equity Management, an investment management firm, published its “Global Opportunities Fund” second quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
August 5 - Hedge Fund Investor Letters, News - Comments
Is Pacific Biosciences of California, Inc.
Keep Reading →
July 20 - Hedge Funds, News - Comments
In this article, we discuss the 10 best tech stocks to buy according to Japanese billionaire Masayoshi Son.
Keep Reading →
June 29 - Hedge Funds, News - Comments
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
Keep Reading →
May 25 - Hedge Funds, News - Comments
Baron Funds, an asset management firm, published its "Baron Health Care Fund" first quarter 2021 investor letter – a copy of which can be downloaded here.
Keep Reading →
April 30 - Hedge Fund Investor Letters, News - Comments
A whopping number of 13F filings filed with U.S.
Keep Reading →
April 24 - Hedge Funds, News - Comments
In this article we will take a look at the 10 best pharma stocks to buy now.
Keep Reading →
March 25 - Hedge Funds, News - Comments
In this article, we examined Billionaire Masayoshi Son's investment strategy that helped him in generating billions of dollars in profits last year.
Keep Reading →
March 16 - Hedge Funds, News - Comments
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Keep Reading →
February 2 - Hedge Fund Investor Letters, News - Comments
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Keep Reading →
December 3 - Hedge Fund Investor Letters, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
October 6 - Hedge Funds, News - Comments
After first opposing a merger with Global Blue, the hedge fund manager backed down. Dan Loeb’s troubled Far Point Acquisition Corp.
Keep Reading →
August 25 - Hedge Funds, Insider Trading - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
August 10 - Hedge Funds, News - Comments
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Keep Reading →
June 23 - Hedge Funds, News - Comments
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
December 7 - Hedge Funds, News - Comments
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.
Keep Reading →
October 28 - Hedge Funds, News - Comments
We at Insider Monkey have gone over 738 13F filings that hedge funds and famous value investors are required to file by the SEC.
Keep Reading →
June 19 - Hedge Funds, News - Comments
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Keep Reading →
May 2 - Hedge Funds, News - Comments
Among the biggest Havens Advisors fourth quarter holdings that weren’t sold out in the meantime was Red Hat Inc (NYSE:RHT), a software company which offers a variety of open...
Keep Reading →
April 23 - Hedge Funds, News - Comments
Pacific Biosciences of California (NASDAQ:PACB) has received a purchase order for its sequel systems from GrandOmics.
Keep Reading →
January 5 - News, Stock Analysis - Comments
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Keep Reading →
December 9 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization...
Keep Reading →
October 8 - Hedge Funds, News - Comments
According to a newly-amended 13G filing with the US Securities and Exchange Commission, Roberto Mignone's Bridger Management owns 4.46 million shares of Pacific Biosciences...
Keep Reading →
April 27 - Hedge Funds, News - Comments
The hedge fund industry is required to file quarterly 13F filings within 45 days after the end of each fiscal quarter.
Keep Reading →
April 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
U.S stocks are slightly higher in early afternoon trading following some choppy morning trading.
Keep Reading →
February 4 - Earnings Report, Market Movers, News - Comments
With the market trying to stay above sea-level in afternoon trading on Monday, Chiasma Inc (NASDAQ:CHMA), Pacific Biosciences of California (NASDAQ:PACB), Fitbit Inc (NYSE:FIT...
Keep Reading →
January 11 - Market Movers, News - Comments
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Keep Reading →
November 30 - Hedge Funds, News - Comments
Sarepta Therapeutics Inc (NASDAQ:SRPT), Pacific Biosciences of California (NASDAQ:PACB), and Evoke Pharma Inc (NASDAQ:EVOK) are trending today as their shares are up by 22%, ...
Keep Reading →
October 1 - News - Comments
To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest.
Keep Reading →
September 15 - News - Comments
Incyte Corporation (NASDAQ:INCY) takes the top spot on our humongous health-care stocks list.
Keep Reading →
August 26 - News - Comments
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 19 - News - Comments
To most investors, hedge funds are assumed to be worthless, old investment tools of the past.
Keep Reading →
June 17 - News - Comments
Insider buying is widely considered a positive indicator for any company. This holds truer for biotechnology companies because valuations are linked to pipeline candidates.
Keep Reading →
June 7 - News - Comments
Is Pacific Biosciences of California (NASDAQ:PACB) the right pick for your portfolio? Investors who are in the know are getting more optimistic.
Keep Reading →
April 15 - News - Comments
The global economy is still going through the initial stages of recovery and waiting on positive news from European markets.
Keep Reading →
March 19 - Insider Trading - Comments